A member of the Sackler family that owns Purdue Pharma testified on Tuesday that his family bears a “moral responsibility” to help abate the U.S. opioid crisis but said it will not contribute financially to the effort unless it receives …
Purdue Pharma LP and its owners, members of the Sackler family, are nearing the end of their decades-long association with opioids, seeking court approval to pay billions of dollars and walk away from the business that helped make their fortune. …
Governor Andrew M. Cuomo has announced a $4.5 billion settlement with Purdue Pharma over the company’s role in falsely marketing its products. The owners of Purdue Pharma, the Sackler family, will be required to pay $4.5 billion over the next …
Purdue Pharma LP won the support of more than a dozen states that had opposed its $4.5 billion bankruptcy plan after members of the Sackler family that own it agreed to pay more money and relinquish control of two family …
New York City and 21 of New York’s counties on Tuesday announced a lawsuit against consulting firm McKinsey & Company, accusing the company of contributing to the opioid crisis by helping create strategies to increase prescription drug sales. In the …
Massachusetts’ top prosecutor on Thursday sued a global marketing company that she alleges played a role in fueling the opioid epidemic. State Attorney General Maura Healey said Publicis Health designed and deployed unfair and deceptive marketing schemes to help Purdue …
Members of the Sackler family who own Purdue Pharma LP have offered roughly $4.3 billion to resolve sprawling opioid litigation, up from $3 billion initially proposed in settlement discussions underway in the OxyContin maker’s bankruptcy proceedings, four people familiar with …
Members of the wealthy Sackler family, owners of OxyContin maker Purdue Pharma LP, have long denied that the $10 billion they transferred from their company over the course of a decade was an unlawful attempt to shield assets in anticipation …
U.S. states claimed they are owed $2.2 trillion to address harm from OxyContin maker Purdue Pharma LP’s alleged role in America’s opioid epidemic, accusing the drugmaker in new filings of pushing prescription painkillers on doctors and patients while playing down …
U.S. prosecutors are pursuing possible penalties of nearly $13 billion to resolve investigations of OxyContin maker Purdue Pharma after uncovering evidence of criminal and civil misconduct stemming from the company’s alleged role in fueling the nation’s opioid crisis, people familiar …
